Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 08/31/09
Due: 08/31/10
Phase: N/A
Priority: Normal
Start: 04/30/07
End: 02/29/08
Due: 02/28/09
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients | NCT00635765 | Ambrilia Biopharma, Inc. | user2@example.com | None | 2007-10-31 | 2009-06-30 | 2010-06-30 | - | - | 2025-07-14 |
| Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients | NCT00642421 | Ambrilia Biopharma, Inc. | user2@example.com | None | 2008-02-29 | 2009-08-31 | 2010-08-31 | - | - | 2025-07-14 |
| Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients | NCT00616551 | Ambrilia Biopharma, Inc. | user2@example.com | None | 2007-04-30 | 2008-02-29 | 2009-02-28 | - | - | 2025-07-14 |